CVS Health (CVS)
(Delayed Data from NYSE)
$57.81 USD
-1.51 (-2.55%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $57.63 -0.18 (-0.31%) 5:18 PM ET
4-Sell of 5 4
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.81 USD
-1.51 (-2.55%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $57.63 -0.18 (-0.31%) 5:18 PM ET
4-Sell of 5 4
A Value A Growth B Momentum A VGM
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Top Research Reports with Q2 Earnings Analysis: Merck, CVS Health, CME Group & More
by Kalyan Nandy
Today's Research Daily features updated research reports on 16 major stocks, including Merck (MRK), CVS Health (CVS) and CME Group (CME).
CVS Health's (CVS) Q2 Earnings Beat Estimate, Margins Up
by Zacks Equity Research
CVS Health (CVS) reports strong Pharmacy Services revenues, benefiting from the upside in the specialty services. Year-over-year Retail/LTC comparisons are also encouraging.
Stock Index Futures Lower On Wednesday
by Zacks Equity Research
Stock Index Futures Lower On Wednesday
Indexes Start Lower As Trade Worries Persist
by Zacks Equity Research
U.S. stock index futures were lower on Wednesday as global trade war fears continue to dent investor confidence despite a robust second-quarter 2018 earnings season
Buy These 6 Low Price-to-Book Stocks for Handsome Returns
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
CVS Health (CVS) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 4.97% and 0.68%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Buy Amazon (AMZN) Stock On Possible Gas Station & Travel Push?
by Benjamin Rains
Shares of Amazon (AMZN) popped Tuesday after D.A. Davidson analysts suggested that the next logical industries for the e-commerce giant to enter would be gas stations and travel. Amazon could likely jump into the gas station market without much fuss, similar to Costco (COST), and certainly has the online infrastructure and customer base to offer travel deals. But what should investors make of this?
Should Value Investors Pick CVS Health (CVS) Stock Now?
by Zacks Equity Research
Let's see if CVS Health Corporation (CVS) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Rite Aid Stock Falls on FY19 View Cut Ahead of Merger Vote
by Zacks Equity Research
Rite Aid (RAD) lowers fiscal 2019 guidance as the generic drug purchasing efficiencies fall below expectations. Rite Aid shareholders are likely to vote for the Albertsons merger on Aug 9.
Why Amazon (AMZN) Stock Is A Strong Buy Right Now
by Benjamin Rains
Nearly everyone knows that Amazon (AMZN) stock has been one of the hottest on Wall Street for years. Yet some assume now is too late to get in on the fun, which simply isn't true. So let's take a look at why investors should buy Amazon stock right now following yet another quarter of stellar growth.
Why Apple Pay, AirPods, & Services Are More Vital Than Ever
by Benjamin Rains
Apple (AAPL) saw its stock price climb Wednesday as it inches ever closer to that elusive $1 trillion market cap. The firm's iPhone revenues surged once again during its fiscal Q3, but investors seem much more excited about Apple's growing Services unit, which features Apple Music, Apple Pay, along with other newer businesses.
Apple Earnings Preview, Chipotle Woes, News from NAKD, CVS, SHOP | Free Lunch
by Ryan McQueeney
Ryan McQueeney discusses Chipotle's latest foodborne illness trouble, the new partnership between Naked Brands and CVS, and Shopify's earnings report. Later, he is joined by Zacks Strategist Brian Bolan to preview the upcoming earnings announcement of tech behemoth Apple.
Is CVS Health (CVS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What's in the Cards for CVS Health (CVS) in Q2 Earnings?
by Zacks Equity Research
CVS Health (CVS) is optimistic about living up to its strong earnings surprise history year over year in Q2 as well, courtesy of gains from the Pharmacy Services segment.
5 Low Price-to-Book Stocks That Can Prove to be Valuable
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
One of Wall Street's Top Analysts Warns Against Trade War
by Chloe Shin
With the trade war looming upon us, Goldman Sachs chief U.S. equity strategist David Kostin warned investors about how it will affect U.S. Companies. According to Kostin, if trade tensions worsen, and a 10 percent tariff were imposed on all U.S. imports, Goldman would lower its 2019 S&P 500 EPS estimate by 15 percent.
Zacks.com featured highlights include: ConocoPhillips, Archer Daniels, CVS, Fortinet and Avnet
by Zacks Equity Research
Zacks.com featured highlights include: ConocoPhillips, Archer Daniels, CVS, Fortinet and Avnet
The Zacks Analyst Blog Highlights: CVS, RH, Groupon, Darden and Carrols
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CVS, RH, Groupon, Darden and Carrols
5 Stocks Trading Near 52-Week High With More Room to Run
by Zacks Equity Research
Here are some stocks trading near their 52-week high levels with potential to scale higher.
Americans on a Spring Spending Spree: Top 5 Gainers
by Tirthankar Chakraborty
Big burst of spending in spring after a ho-hum winter is primarily backed by Trump's tax cuts, strong hiring and declining unemployment rate.
Buy Walgreens (WBA) Stock Because It's Cheap & Amazon Fears Are Overblown?
by Benjamin Rains
Shares of Walgreens Boots Alliance (WBA) are down 16.5% over the last year based mostly on Amazon (AMZN) fears. There is no doubt that online selling and delivery have altered the retail world, but does that mean Walgreens can no longer compete? Let's dive into some of WBA's fundamentals to see what to do with the stock.
4 Retail Stocks to Buy as Q2 Earnings Season Knocks
by Sumit Singh
Search for safe havens has intensified ever since the trade hostility between the United States and China commenced. However, its high time that you bury the trade related fears and rejig your portfolio.
Trade Wars and Recessions: What Should Investors Do?
by Tracey Ryniec
The best thing investors can do is have a plan. Find out where you should be investing in this uncertain market.
Amazon Forays Into Pharmacy Business: Red Alert for Others?
by Sweta Jaiswal
Amazon's entry into the high-potential pharmaceutical industry deals a blow to share prices of major players.
Will Healthcare Buck Up on Amazon's Pillpack Takeover Deal?
by Sapna Bagaria
Amazon's (AMZN) use of technology, innovative strategies and skilled leadership should take it far in the healthcare space.